Skip to content

Analysis of Oral-Gut Microbial Communities and Their Metabolism in Patients with Helicobacter pylori Infection

Analysis of Oral-Gut Microbial Communities and Their Metabolism in Patients with Helicobacter pylori Infection

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098935
Enrollment
Unknown
Registered
2025-03-17
Start date
2025-03-31
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori Infection

Interventions

Helicobacter pylori infection group:None
Normal control group:None

Sponsors

Huadong hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1). Age between 18 and 60 years; (2). For the H. pylori-infected group, diagnosis must be confirmed by a carbon-13 urea breath test or rapid urease test during gastroscopy; for the healthy control group, there should be no significant gastrointestinal discomfort symptoms, and the urea breath test must be negative; (3). Relatively stable dietary habits with no major changes in diet structure, and similar lifestyle, dietary habits, and occupational activities; (4). Willingness to participate in the experiment and signing of the informed consent form; (5). Body Mass Index (BMI) between 18 and 24; (6). Absence of underlying digestive system diseases.

Exclusion criteria

Exclusion criteria: (1). Previous standardized treatment for Helicobacter pylori eradication; (2). Use of antibiotics, bismuth preparations, probiotics, etc., within the last 4 weeks, or use of potassium-competitive acid blockers, PPIs (proton pump inhibitors), or H2 receptor antagonists within the last 2 weeks; (3). Concurrent use of non-steroidal anti-inflammatory drugs (NSAIDs), systemic corticosteroids, anticoagulants, or excessive alcohol consumption during the treatment period; (4). Smokers; (5). Presence of systemic diseases; (6). Pregnancy or lactation; (7). Inability or unwillingness to participate in this clinical study.

Design outcomes

Primary

MeasureTime frame
oral Microbial Communities;gut Microbial Communities;Metabolism;

Countries

China

Contacts

Public ContactXiaowen Li

Huadong hospital, Fudan University

muziyu3030@126.com+86 137 7443 1973

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026